Department of Defense grant to test promising treatment for triple-negative breast cancer

(University of Illinois at Chicago) A unique cell surface protein found on triple-negative type breast cancer cells called JAG1 is a promising new therapeutic target for this hard-to-treat and highly metastatic type of breast cancer, according to researchers at the University of Illinois at Chicago.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news